EV/EBITDA
-3.82
+0.11+2.80%
10 min ago
Summary:
Galectin Therapeutics EV/EBITDA is currently -3.82, with a rise of +0.11 (+2.80%) during the most recent trading day. Over the past year, it has increased by +0.20 (+4.98%). GALT EV/EBITDA is now -7740.00% below its all-time high of 0.05.GALT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +2.8% |
| 1 m1 month | +40.4% |
| 3 m3 months | +37.6% |
| 6 m6 months | +30.8% |
| ytdytd | +2.8% |
| 1 y1 year | +5.0% |
| 5 y5 years | +56.1% |
GALT EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -3.21 | -19.0% | -6.41 | +40.4% |
| 3 m | 3 months | -3.21 | -19.0% | -6.71 | +43.1% |
| 6 m | 6 months | -3.21 | -19.0% | -6.71 | +43.1% |
| 1 y | 1 year | -3.21 | -19.0% | -8.54 | +55.3% |
| 3 y | 3 years | -2.05 | -86.3% | -8.54 | +55.3% |
| 5 y | 5 years | -2.05 | -86.3% | -10.37 | +63.2% |
| alltime | all time | 0.05 | -7740.0% | -35.88 | +89.3% |
Galectin Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.82(-2.8%) |
| 2024 | -3.93(+1.0%) |
| 2023 | -3.89(+66.2%) |
| 2022 | -2.34(-37.4%) |
| 2021 | -3.74(-13.4%) |
| 2020 | -4.32(-50.6%) |
| 2019 | -8.75(-10.8%) |
| 2018 | -9.81(+36.6%) |
| 2017 | -7.18(+808.9%) |
| 2016 | -0.79(-26.2%) |
| 2015 | -1.07(-65.7%) |
| 2014 | -3.12(-72.7%) |
| Date | Value |
|---|---|
| 2013 | -11.42(+379.8%) |
| 2012 | -2.38(-61.9%) |
| 2011 | -6.24(-41.1%) |
| 2010 | -10.60(+351.1%) |
| 2009 | -2.35(+193.8%) |
| 2008 | -0.80(-81.0%) |
| 2007 | -4.21(+111.6%) |
| 2006 | -1.99(-83.4%) |
| 2005 | -11.99(+49.1%) |
| 2004 | -8.04(-55.5%) |
| 2003 | -18.05(+3.9%) |
| 2002 | -17.37 |
FAQ
- What is Galectin Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Galectin Therapeutics?
- What is GALT EV/EBITDA year-to-date change?
- What is Galectin Therapeutics EV/EBITDA year-on-year change?
What is Galectin Therapeutics EV/EBITDA?
The current EV/EBITDA of GALT is -3.82
What is the all time high EV/EBITDA for Galectin Therapeutics?
Galectin Therapeutics all-time high EV/EBITDA is 0.05
What is GALT EV/EBITDA year-to-date change?
Galectin Therapeutics EV/EBITDA has changed by +0.11 (+2.80%) since the beginning of the year
What is Galectin Therapeutics EV/EBITDA year-on-year change?
Over the past year, GALT EV/EBITDA has changed by +0.20 (+4.98%)